MYOPIA AND PRESBYOPIA TREATMENT MARKET ANALYSIS

Market Challenges And Opportunities

Global Myopia and Presbyopia Market - Drivers

Increasing government approvals for the treatment of myopia

Increasing government approvals are expected to drive the global myopia and presbyopia market growth over the forecast period. For instance, on May 12, 2021, Johnson & Johnson Vision, announced that the U.S. Food and Drug Administration (FDA) has approved ACUVUE Abiliti overnight therapeutic lenses for myopia management. Abiliti overnight orthokeratology (ortho-k) lenses are specifically designed and fitted to match a patient’s eye based on its unique corneal shape to temporarily reshape the cornea.

Global Myopia and Presbyopia Market: Restraints

Complications associated with the treatment of myopia

Complications associated with the treatment of myopia a thorough ophthalmologic examination must be conducted, including an evaluation of visual acuity, refraction, intraocular pressure, fundoscopic examination, corneal thickness, and corneal topography. On May 24, 2021, National Center for Biotechnology Information published an article explaining because some restrictions and complications related to excimer laser correction still exist. Assessment of the biomechanical characteristics of the cornea may be useful, but research is ongoing. The correction of refractive error may not be possible due to thin corneas and/or topographic abnormalities such as keratoconus. In addition to the flap, diffuse lamellar keratite, corneal ectasia, and dry eye in LASIK correction, complications can include haze and postoperative pain in Photorefractive keratectomy (PRK) PRK. In the presbyopic age group, Laser-Assisted In Situ Keratomileusis (LASIK) and PRK for myopia and hyperopia have demonstrated acceptable safety, efficacy, and predictability profiles.

To counterbalance this restraint, more research and development should be conducted to avoid the complications in surgeries and treatments.